Exploring the mixed marketing authorisation pathway: a case study in ophthalmology

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1Learning from the EMA experience: common CMC deficiencies in marketing authorisation applications over the past decade2025
2. 2MARKETING AUTHORIZATION OF PHARMACEUTICALS IN UNITED STATES (US), EUROPEAN UNION (EU) AND INDIAOriginal Research · 2026
3. 3Balancing ethical norms and duties for the introduction of new medicines through conditional marketing authorization: a research agenda2024 · 5 citations
4. 4From complexity to approval in the European Union: regulatory pathways and data challenges in the evaluation of non-oncology orphan medicinesOriginal Research · 2026
5. 5Comparison of Combination Product Regulations: Challenges and approval pathway in the US and Europe2025